Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, Or Go Hybrid?
June 22, 2021. 2:00PM EST/ 7.00PM GMT
Companies developing advanced therapies have to decide early on: Build capacity, and how much? Outsource, and how little? Mix and Match, and how effective? One thing is certain: You need to clearly understand the opportunities and risks with these three models. Fortunately, there are guiding principles and best practices for getting these individual assessments right.
Join Evelyn Kelly, Managing Director of Orphan Drug Consulting,
Todd Mabe, VP of GMP Quality Akouos, Inc,
Joseph Graskemper, Associate Director, CMC Strategy Translate Bio and,
Louis Garguilo Chief Editor & Event Chair Outsourced Pharma
as the panel of experts share their immense industry knowledge on the principles of Advanced Therapy Conundrum and experience on 22 June, courtesy of Outsourced Pharma.
for the upcoming webinar
